Picture of HALEON logo

HLN HALEON News Story

0.000.00%
gb flag iconLast trade - 00:00
HealthcareAdventurousLarge CapFalling Star

REG - Haleon PLC - Annual Financial Report 2022 and Notice of AGM

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20230320:nRST5649Ta&default-theme=true

RNS Number : 5649T  Haleon PLC  20 March 2023

 

 

Annual Financial Report 2022 and Notice of AGM

 

20 March 2023: Haleon plc (the "Company") (LSE/NYSE: HLN) today announces that
the following documents have been made available to shareholders:

 

1.       Annual Report and Form 20-F 2022

2.       Notice of 2023 Annual General Meeting (AGM)

3.       Form of Proxy for the 2023 AGM

4.       AGM Voting Instruction Card

 

A copy of each of the documents has been submitted to the National Storage
Mechanism and will shortly be available for inspection
at https://data.fca.org.uk/#/nsm/nationalstoragemechanism
(https://data.fca.org.uk/#/nsm/nationalstoragemechanism) .

 

The Company will also file the Annual Report and Form 20-F 2022 with the US
Securities and Exchange Commission today.

 

The documents referred to above are publicly available on the Company's
website at www.haleon.com (http://www.haleon.com) .

 

In compliance with the Disclosure Guidance and Transparency Rules, the Annual
Report and Form 20-F 2022, as submitted to the National Storage Mechanism,
contains regulated information in unedited full text and is available on the
Company's website as noted above.

 

Shareholders may request a hard copy of the Annual Report and Form 20-F 2022,
including the complete audited financial statements of the Company, free of
charge from: Company Secretariat, Haleon plc, Building 5, First Floor, The
Heights, Weybridge, KT13 0NY, United Kingdom.

 

Amanda Mellor, Company Secretary

 

About Haleon

Haleon (LSE / NYSE: HLN) is a global leader in consumer health, with a purpose
to deliver better everyday health with humanity. Haleon's product portfolio
spans five major categories - Oral Health, Pain Relief, Respiratory Health,
Digestive Health and Other, and Vitamins, Minerals and Supplements (VMS). Its
long-standing brands - such as Advil, Sensodyne, Panadol, Voltaren, Theraflu,
Otrivin, Polident, parodontax and Centrum - are built on trusted science,
innovation and deep human understanding.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  ACSBUGDXGGDDGXG

Recent news on HALEON

See all news